Animal Models Core Animal models are essential tools in medical research. For diseases with a genetic component and those with potential treatments through nanotechnology therapy, pre-clinical in vivo studies are required for the development of optimal and safe procedures. The UNC Animal Models Core consists of two components. First, the UNC Animal (Mouse) Models Core is the UNC facility that provides all procedures involved in the generation of genetically engineered mice. This facility will provide CCNE investigators with efficient production of such animals, should they be needed. More importantly, a colony of animals will be established to maintain and genotype lines of mice that are provided exclusively to CCNE investigators for experimental studies. The breeding core will be administratively linked to and supervised by the Mouse Models Core. The mouse is the only practical mammal in which the model systems needed by the CCNE can used for therapeutic manipulation. This is because it is relatively easy to introduce genes into the mouse to achieve cell-specific expression and to modify endogenous loci to generate cancer models. The majority of the projects described by CCNE investigators in this application (4 of 5) will require mice. For some projects, existing mutant strains will suffice and the Mouse Models Core will maintain a colony of these animals and produce them for the investigators as needed. For other projects, new transgenic and/or gene-targeted mouse lines may be required. To this end, the core will a) assist investigators in designing transgenic and gene targeting vectors, b) provide genomic clones and plasmid backbones to the investigator for constructing the vectors, c) create new transgenic and gene-targeted mouse lines for the investigators, d) breed and genotype the animals for experiments and e) assist in experimental procedures. In addition, associated technologies, such as cryopreservation and ovary transplants, are also available to support CCNE research efforts. An executive committee consisting of Drs. Juliano, Earp and Van Dyke will oversee the interactions of the CCNE with the animal models core. This committee will monitor usage, determine needs and mediate decisions if usage extends beyond anticipated levels.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA119343-03
Application #
7550627
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
3
Fiscal Year
2007
Total Cost
$113,585
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bowerman, Charles J; Byrne, James D; Chu, Kevin S et al. (2017) Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer. Nano Lett 17:242-248
Giovinazzo, Hugh; Kumar, Parag; Sheikh, Arif et al. (2016) Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemother Pharmacol 77:565-73
Koh, Ai Leen; Gidcumb, Emily; Zhou, Otto et al. (2016) Oxidation of Carbon Nanotubes in an Ionizing Environment. Nano Lett 16:856-63
Burk, Laurel M; Wang, Ko-Han; Wait, John Matthew et al. (2015) Delayed contrast enhancement imaging of a murine model for ischemia reperfusion with carbon nanotube micro-CT. PLoS One 10:e0115607
Chu, Kevin S; Finniss, Mathew C; Schorzman, Allison N et al. (2014) Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity. Nano Lett 14:1472-6
Chhetri, Raghav K; Blackmon, Richard L; Wu, Wei-Chen et al. (2014) Probing biological nanotopology via diffusion of weakly constrained plasmonic nanorods with optical coherence tomography. Proc Natl Acad Sci U S A 111:E4289-97
Song, Gina; Petschauer, Jennifer S; Madden, Andrew J et al. (2014) Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases. Curr Rheumatol Rev 10:22-34
Casbas-Hernandez, Patricia; D'Arcy, Monica; Roman-Perez, Erick et al. (2013) Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res 15:R82
Valencia, C Alexander; Zou, Jianwei; Liu, Rihe (2013) In vitro selection of proteins with desired characteristics using mRNA-display. Methods 60:55-69
Chtcheprov, Pavel; Hadsell, Michael; Burk, Laurel et al. (2013) Physiologically gated micro-beam radiation therapy using electronically controlled field emission x-ray source array. Proc SPIE Int Soc Opt Eng 8671:

Showing the most recent 10 out of 92 publications